Elevated levels of activin A in clinical and experimental pulmonary hypertension

Journal of Applied Physiology

Volumn 106, Issue 4, 2009, Pages 1356-1364

  Yndestad, Arne ^a   Larsen, Karl Otto ^b,c   Øie, Erik ^c,d   Ueland, Thor ^a,d   Smith, Camilla ^a   Halvorsen, Bente ^a   Sjaastad, Ivar ^b,c   Skjønsberg, Ole Henning ^b   Pedersen, Turid M ^a   Anfinsen, Ole Gunnar ^d   Damås, Jan Kristian ^a,d   Christensen, Geir ^b,c   Aukrust, Pål ^a,d   Andreassen, Arne K ^c,d  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^c UNIVERSITY OF OSLO   (Norway)

^d OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Growth factors; Inflammation; Pathogenesis

Indexed keywords

ACTIVIN A; ENDOTHELIN 1; FOLLISTATIN; MESSENGER RNA; PLASMINOGEN ACTIVATOR INHIBITOR 1; SMAD2 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; ACTIVIN; CYTOKINE; RNA; SMAD2 PROTEIN, HUMAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; EXPERIMENTAL MODEL; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG ALVEOLUS CELL; LUNG ALVEOLUS MACROPHAGE; MALE; MORTALITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS; PULMONARY HYPERTENSION; SMOOTH MUSCLE FIBER; UPREGULATION; ADULT; ANIMAL; BIOSYNTHESIS; BLOOD; BLOOD PRESSURE; C57BL MOUSE; CYTOLOGY; ENDOTHELIUM CELL; ENZYME IMMUNOASSAY; GENETICS; METABOLISM; MIDDLE AGED; PATHOLOGY; PHOSPHORYLATION; PHYSIOLOGY; PULMONARY ARTERY; WESTERN BLOTTING;

ACTIVINS; ADULT; ANIMALS; BLOOD PRESSURE; BLOTTING, WESTERN; CELL PROLIFERATION; CYTOKINES; ENDOTHELIAL CELLS; ENDOTHELIN-1; FEMALE; FOLLISTATIN; HUMANS; HYPERTENSION, PULMONARY; IMMUNOENZYME TECHNIQUES; MALE; MICE; MICE, INBRED C57BL; MIDDLE AGED; MYOCYTES, SMOOTH MUSCLE; PHOSPHORYLATION; PULMONARY ARTERY; RNA; SMAD2 PROTEIN; UP-REGULATION;

EID: 66149139387     PISSN: 87507587     EISSN: 15221601     Source Type: Journal    
DOI: 10.1152/japplphysiol.90719.2008     Document Type: Article

References (32)

1. Amthor H, Nicholas G, McKinnell I, Kemp CF, Sharma M, Kambadur R, Patel K. Follistatin complexes myostatin and antagonises myostatin-mediated inhibition of myogenesis. Dev Biol 270: 19-30, 2004. (Pubitemid 38596926)
2. Aoki F, Kurabayashi M, Hasegawa Y, Kojima I. Attenuation of bleomycin-induced pulmonary fibrosis by follistatin. Am J Respir Crit Care Med 172: 713-720, 2005. (Pubitemid 41324226)
3. Blobe GC, Schiemann WP, Lodish HF. Role of transforming growth factor beta in human disease. N Engl J Med 342: 1350-1358, 2000.
4. Borawski J, Naumnik B, Mysliwiec M. Activation of hepatocyte growth factor/activin A/follistatin system during hemodialysis: role of heparin. Kidney Int 64: 2229-2237, 2003. (Pubitemid 37449559)
5. Chen Y, Budd RC, Kelm RJ Jr, Sobel BE, Schneider DJ. Augmentation of proliferation of vascular smooth muscle cells by plasminogen activator inhibitor type 1. Arterioscler Thromb Vasc Biol 26: 1777-1783, 2006. (Pubitemid 44305331)
6. Chen YF, Feng JA, Li P, Xing D, Zhang Y, Serra R, Ambalavanan N, Majid-Hassan E, Oparil S. Dominant negative mutation of the TGF-beta receptor blocks hypoxia-induced pulmonary vascular remodeling. J Appl Physiol 100: 564-571, 2006. (Pubitemid 43671609)
7. Chen YG, Lui HM, Lin SL, Lee JM, Ying SY. Regulation of cell proliferation, apoptosis, and carcinogenesis by activin. Exp Biol Med (Maywood) 227: 75-87, 2002.
8. Cho SH, Yao Z, Wang SW, Alban RF, Barbers RG, French SW, Oh CK. Regulation of activin A expression in mast cells and asthma: its effect on the proliferation of human airway smooth muscle cells. J Immunol 170: 4045-4052, 2003. (Pubitemid 36428166)
9. Cogan JD, Pauciulo MW, Batchman AP, Prince MA, Robbins IM, Hedges LK, Stanton KC, Wheeler LA, Phillips JA 3rd, Loyd JE, Nichols WC. High frequency of BMPR2 exonic deletions/duplications in familial pulmonary arterial hypertension. Am J Respir Crit Care Med 174: 590-598, 2006.
10. Damås JK, Otterdal K, Yndestad A, Aass H, Solum NO, Frøland SS, Simonsen S, Aukrust P, Andreassen AK. Soluble CD40 ligand in pulmonary arterial hypertension: possible pathogenic role of the interaction between platelets and endothelial cells. Circulation 110: 999-1005, 2004. (Pubitemid 39136216)
11. DeYoung MB, Tom C, Dichek DA. Plasminogen activator inhibitor type 1 increases neointima formation in balloon-injured rat carotid arteries. Circulation 104: 1972-11971, 2001. (Pubitemid 32983243)
12. Farber HW, Loscalzo J. Pulmonary arterial hypertension. N Engl J Med 351: 1655-1665, 2004.
13. Galie N, Manes A, Branzi A. The endothelin system in pulmonary arterial hypertension. Cardiovasc Res 61: 227-237, 2004. (Pubitemid 38091763)
14. Halvorsen B, Ranheim T, Nenseter MS, Huggett AC, Drevon CA. Effect of a coffee lipid (cafestol) on cholesterol metabolism in human skin fibroblasts. J Lipid Res 39: 901-912, 1998. (Pubitemid 28163290)
15. Harada K. Shintani Y. Sakamoto Y.
16. Harada K, Shintani Y, Sakamoto Y, Wakatsuki M, Shitsukawa K, Saito S. Serum immunoreactive activin A levels in normal subjects and patients with various diseases. J Clin Endocrinol Metab 81: 2125-2130, 1996. (Pubitemid 26176707)
17. Hoeper MM, Sosada M, Fabel H. Plasma coagulation profiles in patients with severe primary pulmonary hypertension. Eur Respir J 12: 1446-1449, 1998. (Pubitemid 29011445)
18. Humbert M, Morrell NW, Archer SL, Stenmark KR, MacLean MR, Lang IM, Christman BW, Weir EK, Eickelberg O, Voelkel NF, Rabinovitch M. Cellular and molecular pathobiology of pulmonary arterial hypertension. J Am Coll Cardiol 43: 13S-24S, 2004. (Pubitemid 38759713)
19. Jaffe EA, Nachman RL, Becker CG, Minick CR. Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J Clin Invest 52: 2745-2756, 1973.
20. Larsen KO, Sjaastad I, Svindland A, Krobert KA, Skjonsberg OH, Christensen G. Alveolar hypoxia induces left ventricular diastolic dysfunction and reduces phosphorylation of phospholamban in mice. Am J Physiol Heart Circ Physiol 291: H507-H516, 2006. (Pubitemid 44175055)
21. Loria P, Petraglia F, Concari M, Bertolotti M, Martella P, Luisi S, Grisolia C, Foresta C, Volpe A, Genazzani AR, Carulli N. Influence of age and sex on serum concentrations of total dimeric activin A. Eur J Endocrinol 139: 487-492, 1998. (Pubitemid 28539702)
22. Matsuse T, Ikegami A, Ohga E, Hosoi T, Oka T, Kida K, Fukayama M, Inoue S, Nagase T, Ouchi Y, Fukuchi Y. Expression of immunoreactive activin A protein in remodeling lesions associated with interstitial pulmonary fibrosis. Am J Pathol 148: 707-713, 1996. (Pubitemid 126660663)
23. Ohga E, Matsuse T, Teramoto S, Katayama H, Nagase T, Fukuchi Y, Ouchi Y. Effects of activin A on proliferation and differentiation of human lung fibroblasts. Biochem Biophys Res Commun 228: 391-396, 1996. (Pubitemid 26396085)
24. Pangas SA, Woodruff TK. Activin signal transduction pathways. Trends Endocrinol Metab 11: 309-314, 2000.
25. Rich S, Dantzker DR, Ayres SM, Bergofsky EH, Brundage BH, Detre KM, Fishman AP, Goldring RM, Groves BM, Koerner SK, et al. Primary pulmonary hypertension. A national prospective study. Ann Intern Med 107: 216-223, 1987. (Pubitemid 17137857)
26. Richter A, Yeager ME, Zaiman A, Cool CD, Voelkel NF, Tuder RM. Impaired transforming growth factor-beta signaling in idiopathic pulmonary arterial hypertension. Am J Respir Crit Care Med 170: 1340-1348, 2004. (Pubitemid 39657199)
27. Simonneau G, Galie N, Rubin LJ, Langleben D, Seeger W, Domenighetti G, Gibbs S, Lebrec D, Speich R, Beghetti M, Rich S, Fishman A. Clinical classification of pulmonary hypertension. J Am Coll Cardiol 43: 5S-12S, 2004. (Pubitemid 38759712)
28. Smith C, Yndestad A, Halvorsen B, Ueland T, Waehre T, Otterdal K, Scholz H, Endresen K, Gullestad L, Froland SS, Damas JK, Aukrust P. Potential anti-inflammatory role of activin A in acute coronary syndromes. J Am Coll Cardiol 44: 369-375, 2004. (Pubitemid 38950596)
29. Sztrymf B, Coulet F, Girerd B, Yaici A, Jais X, Sitbon O, Montani D, Souza R, Simonneau G, Soubrier F, Humbert M. Clinical outcomes of pulmonary arterial hypertension in carriers of BMPR2 mutation. Am J Respir Crit Care Med 177: 1377-1383, 2008.
30. Wu DD, Lai M, Hughes PE, Sirimanne E, Gluckman PD, Williams CE. Expression of the activin axis and neuronal rescue effects of recombinant activin A following hypoxic-ischemic brain injury in the infant rat. Brain Res 835: 369-378, 1999. (Pubitemid 29343805)
31. Yndestad A, Holm AM, Müller F, Simonsen S, Frøland SS, Gullestad L, Aukrust P. Enhanced expression of inflammatory cytokines and activation markers in T-cells from patients with chronic heart failure. Cardiovasc Res 60: 141-146, 2003. (Pubitemid 38373485)
32. Yndestad A, Ueland T, Øie E, Florholmen G, Halvorsen B, Attramadal H, Simonsen S, Frøland SS, Gullestad L, Christensen G, Damås JK, Aukrust P. Elevated levels of activin A in heart failure: potential role in myocardial remodeling. Circulation 109: 1379-1385, 2004.